After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for plant breeders, enabling access to improved, protected varieties that ...

Janssen filed patent infringement suits in New Jersey and Delaware over proposed copy of blockbuster drug Invega Sustenna | Lawsuits follow appeals court win for J&J in separate action with Teva and ...

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...

LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...

German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer ...

Major team hire by premier European litigation firm | September opening adds to successful UPC practice | Hire is a ‘landmark’ moment says Penny Gilbert. Already registered? If you don't have a login ...

Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental health treatment | Appeals court rejects arguments that patent claims would ...

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...